Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study

被引：0
|
作者：
Julien Castioni
Pedro Marques-Vidal
Nazanin Abolhassani
Peter Vollenweider
Gérard Waeber
机构：
[1] Lausanne university hospital,Department of Medicine, Internal Medicine
来源：
BMC Health Services Research | / 17卷
关键词：
Polypharmacy; Socio-economic; Smoking; Epidemiology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] POINT PREVALENCE STUDY OF PAEDIATRIC POLYPHARMACY
    Steichert, Melina
    Cawello, Willi
    Breur, Johannes M. P. J.
    Male, Christoph
    de Wildt, Saskia N.
    Laeer, Stephanie
    ARCHIVES OF DISEASE IN CHILDHOOD, 2023, 108 (06) : A8 - A9
  • [22] Clinical and biological determinants of P-wave duration: cross-sectional data from the population-based CoLaus|PsyCoLaus study
    Bocchi, Federica
    Marques-Vidal, Pedro
    Pruvot, Etienne
    Waeber, Gerard
    Vollenweider, Peter
    Gachoud, David
    BMJ OPEN, 2020, 10 (11):
  • [23] Age and Gender Differences in the Social Patterning of Cardiovascular Risk Factors in Switzerland: The CoLaus Study
    Stringhini, Silvia
    Spencer, Brenda
    Marques-Vidal, Pedro
    Waeber, Gerard
    Vollenweider, Peter
    Paccaud, Fred
    Bovet, Pascal
    PLOS ONE, 2012, 7 (11):
  • [24] Prevalence and determinants of vitamin D deficiency in the third trimester of pregnancy: a multicentre study in Switzerland
    Krieger, Jean-Philippe
    Cabaset, Sophie
    Canonica, Claudia
    Christoffel, Ladina
    Richard, Aline
    Schroder, Therese
    von Wattenwyl, Begona Lipp
    Rohrmann, Sabine
    Lotscher, Katharina Quack
    BRITISH JOURNAL OF NUTRITION, 2018, 119 (03) : 299 - 309
  • [25] Prevalence of diabetes and impaired glucose regulation in a Swiss population/the CoLaus study
    Firmann, M.
    Mayor, V.
    Mooser, V.
    Paccaud, F.
    Waeber, G.
    Vollenweider, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 364 - 364
  • [26] PSYCHOTROPIC POLYPHARMACY IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH MENTAL DISORDERS: PREVALENCE AND DETERMINANTS
    Medhekar, R.
    Fujimoto, K.
    Aparasu, R. R.
    Bhatara, V
    Johnson, M. L.
    Alonzo, J.
    Schwarzwald, H.
    Chen, H.
    VALUE IN HEALTH, 2017, 20 (05) : A294 - A294
  • [27] Prevalence, specific and non-specific determinants of complementary medicine use in Switzerland: Data from the 2017 Swiss Health Survey
    Meier-Girard, Delphine
    Luthi, Emmanuelle
    Rodondi, Pierre-Yves A.
    Wolf, Ursula A.
    PLOS ONE, 2022, 17 (09):
  • [28] CoLaus study (Lausanne Cohort):: a populational study in the prevalence of cardiovascular risk factors in Lausanne associated with a case study-control of genetic determinants of arterial hypertension
    Frimann, M
    Paccaud, F
    Hayoz, D
    Pécoud, A
    Mooser, V
    Waeber, G
    Vollenweider, P
    DIABETES & METABOLISM, 2006, 32 : S88 - S89
  • [29] Trends in glycemic, blood pressure, and lipid control in adults with diabetes in Switzerland: the CoLaus|PsyCoLaus Study
    Alkandari, Abdullah
    Vaucher, Julien
    Marques-Vidal, Pedro
    BMJ OPEN DIABETES RESEARCH & CARE, 2023, 11 (03)
  • [30] The pattern of medication use, and determinants of the prevalence of polypharmacy among patients with a recent history of depressive disorder: results from the pars cohort study
    Ghaed-Sharaf, Mehrnoosh
    Hariri, Sanam
    Poustchi, Hossein
    Nourollahi, Maryam
    Khani, Sara
    Taherifard, Erfan
    Mohammadi, Zahra
    Hadipour, Maryam
    Sabaei, Rasoul
    Gandomkar, Abdullah
    Malekzadeh, Fatemeh
    Vardanjani, Hossein Molavi
    BMC PSYCHOLOGY, 2022, 10 (01)
12345